Celeste Lebbé

32PUBLICATIONS
249CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Aug 12, 2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Jul 04, 2025
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).

Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera

|May 19, 2025
The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target.

Ikuan Sam, Nadine Ben Hamouda, Marina Alkatrib

Pageof 6

Frequent Collaborators

13 joint publications

Paolo A Ascierto

10 joint publications

Caroline Robert

9 joint publications

Georgina V Long

9 joint publications

Reinhard Dummer